SCHEMBL6134734

SCHEMBL6134734

CCOC(=O)c1ccc(N2CCN(CCCCCCCOC)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.51
KCNH2 Q12809 2/20 0.51
ALDH1A1 P00352 1/20 0.51
TSHR P16473 1/20 0.51
CACNA1F O60840 3/20 0.47
BCHE P06276 3/20 0.47
CACNA1D Q01668 3/20 0.47
CACNA1S Q13698 3/20 0.47
CACNA1C Q13936 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HRH4 Q9H3N8 1/20 0.47
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
SLC29A1 Q99808 1/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
KCNJ1 P48048 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10901028 0.89 KDM4E (0.59) HRH3KCNH2ALDH1A1TSHRTHRA
Hydrochloric Acid SCHEMBL10897562 0.88 KDM4E (0.58) HRH3KCNH2ALDH1A1TSHRTHRA
SCHEMBL6132957 0.87 HRH3 (0.55) HRH3KCNH2ALDH1A1TSHRCACNA1F
SCHEMBL6133614 0.86 DRD3 (0.52) HRH3KCNH2ALDH1A1TSHRMEN1
SCHEMBL3196580 0.85 HSD17B10 (0.53) HRH3KCNH2ALDH1A1TSHRMEN1
SCHEMBL6135617 0.85 MAPT (0.51) HRH3ALDH1A1TSHRHTTDRD3
SCHEMBL8205972 0.83 ALDH1A1 (0.58) KCNH2ALDH1A1TSHRMEN1KMT2A
SCHEMBL6134554 0.83 HRH3 (0.51) HRH3MEN1KMT2ADRD3
SCHEMBL3196574 0.83 ALDH1A1 (0.53) HRH3KCNH2ALDH1A1TSHRMEN1
SCHEMBL6132804 0.83 HPGD (0.46) HRH3KCNH2ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 HRH3 1440/4885KCNH2 2774/4885ALDH1A1 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.